Alliqua BioMedical, Inc.

Alliqua BioMedical, Inc. Announces Closing Asset Sale to Celularity Inc. https://t.co/zRXU7dMA4P

Alliqua BioMedical, Inc. Announces Definitive Asset Purchase Agreement with Celularity, Inc. https://t.co/VdSp1PgRWM

Alliqua BioMedical, Inc. Reports Third Quarter of Fiscal Year 2017 Financial Results and Increases Fiscal Year... https://t.co/xxbHIj4shz

Alliqua BioMedical, Inc. Engages Cowen to Assist in Evaluating Potential Strategic Alternatives https://t.co/TNhLKIObwQ

Alliqua BioMedical, Inc. to Announce Third Quarter of Fiscal Year 2017 Results on November 9th https://t.co/Yz80FJSe9i

Alliqua BioMedical, Inc. Announces 1-for-10 Reverse Stock Split https://t.co/JnQbtRqP37

Alliqua BioMedical, Inc. Announces the Sale of TheraBond 3D Antimicrobial Barrier Systems Product Line; Alliqua... https://t.co/YmX8SO0sQ9

Alliqua BioMedical, Inc. Reports Second Quarter of Fiscal Year 2017 Financial Results https://t.co/7dnUuc4Z23

Alliqua BioMedical, Inc. to Announce Second Quarter of Fiscal Year 2017 Results on August 10th https://t.co/avDomZVrB5

Alliqua BioMedical, Inc. Announces Partnership with Partners Capital Group to Provide UltraMIST Customers with... https://t.co/B53lCHb4MT

Alliqua BioMedical, Inc. Reports First Quarter of Fiscal Year 2017 Financial Results https://t.co/XQy9RAVivj

Alliqua BioMedical, Inc. Receives Extension from Nasdaq to Regain Compliance with Minimum Bid Price Requirement https://t.co/JpTnLW9O9R

Alliqua BioMedical, Inc. to Present New Data at the Spring 2017 Symposium on Advanced Wound Care https://t.co/zFmRQXwjvz